89 related articles for article (PubMed ID: 21455668)
1. Clinical significance of sentinel lymph node isolated tumour cells in breast cancer.
Patani N; Mokbel K
Breast Cancer Res Treat; 2011 Jun; 127(2):325-34. PubMed ID: 21455668
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of sentinel lymph node micrometastasis in breast cancer.
Patani N; Mokbel K
Breast Cancer Res Treat; 2009 Apr; 114(3):393-402. PubMed ID: 18425678
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node micrometastasis in human breast cancer: an update.
Salhab M; Patani N; Mokbel K
Surg Oncol; 2011 Dec; 20(4):e195-206. PubMed ID: 21788132
[TBL] [Abstract][Full Text] [Related]
4. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
6. The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer.
Giobuin SM; Kavanagh DO; Myers E; Doherty AO; Quinn CM; Crotty T; Evoy D; McDermott E
Eur J Surg Oncol; 2009 Dec; 35(12):1257-60. PubMed ID: 19497702
[TBL] [Abstract][Full Text] [Related]
7. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
8. The role of micrometastatic disease in sentinel lymph node in breast cancer.
Rovera F; Frattini F; Chiappa C; Piscopo C; Bianchi V; Dionigi G; Rausei S; Boni L; Dionigi R
Breast J; 2010; 16 Suppl 1():S26-8. PubMed ID: 21050305
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.
Catzeddu T; Bertelli G; Del Mastro L; Venturini M
J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact?
Moore KH; Thaler HT; Tan LK; Borgen PI; Cody HS
Cancer; 2004 Mar; 100(5):929-34. PubMed ID: 14983487
[TBL] [Abstract][Full Text] [Related]
11. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
[TBL] [Abstract][Full Text] [Related]
12. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.
Noguchi M
Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
14. [Axillary lymph node recurrence after sentinel lymph node biopsy for breast cancer].
Mathelin C; Salvador S; Guyonnet JL
J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):253-9. PubMed ID: 17317037
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
[TBL] [Abstract][Full Text] [Related]
17. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
18. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
19. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
Saidi RF; Dudrick PS; Remine SG; Mittal VK
Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
[TBL] [Abstract][Full Text] [Related]
20. Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining.
Imoto S; Ochiai A; Okumura C; Wada N; Hasebe T
Eur J Surg Oncol; 2006 Dec; 32(10):1175-9. PubMed ID: 16979316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]